SEZanne
AbbVie
AbbVie
Hunan Province Tumor Hospital
BioNTech SE
University of Chicago
Akeso
Bristol-Myers Squibb
Swiss Cancer Institute
G1 Therapeutics, Inc.
Anhui Provincial Cancer Hospital
Trans Tasman Radiation Oncology Group
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Fox Chase Cancer Center
Fujian Cancer Hospital
Sichuan University
Columbia University
Weill Medical College of Cornell University
Jeroen Bosch Ziekenhuis
Second Hospital of Shanxi Medical University
Peking Union Medical College Hospital
Guangzhou Institute of Respiratory Disease
Gruppo Oncologico Italiano di Ricerca Clinica
Shandong Cancer Hospital and Institute
Sichuan University
Beijing Chest Hospital, Capital Medical University
Hoosier Cancer Research Network
Harbin Medical University
Guangdong Association of Clinical Trials
Sichuan University
Nanfang Hospital, Southern Medical University
European Organisation for Research and Treatment of Cancer - EORTC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Shanghai Henlius Biotech
SCRI Development Innovations, LLC
NYU Langone Health
Intergroupe Francophone de Cancerologie Thoracique
Taizhou HoudeAoke Biomedical Co., Ltd.
Shanghai Pulmonary Hospital, Shanghai, China
ChineseAMS
Taizhou Hospital
Bristol-Myers Squibb
University of California, Davis
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
SCRI Development Innovations, LLC
GlaxoSmithKline
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
SCRI Development Innovations, LLC